SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
60 hedge funds and large institutions have $48.8M invested in Strongbridge Biopharma plc. in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
1.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
20
Reduced
18
Closed
11
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$6K
Top Buyers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$6.41M |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$734K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$673K |
| 4 |
JPMorgan Chase & Co
New York
|
+$671K |
| 5 |
Renaissance Technologies
New York
|
+$610K |
Top Sellers
| 1 |
PM
Prosight Management
Dallas,
Texas
|
-$2.63M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.37M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.26M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$903K |
| 5 |
D.E. Shaw & Co
New York
|
-$639K |
